105 related articles for article (PubMed ID: 12014667)
1. Cytotoxicity of a series of water-soluble mixed valent diruthenium tetracarboxylates.
Van Rensburg CE; Kreft E; Swarts JC; Dalrymple SR; MacDonald DM; Cooke MW; Aquino MA
Anticancer Res; 2002; 22(2A):889-92. PubMed ID: 12014667
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of a series of ferrocene-containing beta-diketones.
Swarts JC; Vosloo TG; Cronje SJ; Du Plessis WC; Van Rensburg CE; Kreft E; Van Lier JE
Anticancer Res; 2008; 28(5A):2781-4. PubMed ID: 19035310
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of ruthenocene-containing β-diketones.
Kemp KC; Nell MJ; VAN Rensburg CE; Swarts JC
Anticancer Res; 2012 Jul; 32(7):2915-8. PubMed ID: 22753755
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic activity of a series of ferrocene-containing alcohols.
Shago RF; Swarts JC; Kreft E; Van Rensburg CE
Anticancer Res; 2007; 27(5A):3431-3. PubMed ID: 17970091
[TBL] [Abstract][Full Text] [Related]
5. Selective cytotoxic Ru(II) arene Cp* complex salts [R-PhRuCp*](+)X(-) for X = BF4(-), PF6(-), and BPh4(-).
Loughrey BT; Healy PC; Parsons PG; Williams ML
Inorg Chem; 2008 Oct; 47(19):8589-91. PubMed ID: 18783214
[TBL] [Abstract][Full Text] [Related]
6. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
[TBL] [Abstract][Full Text] [Related]
8. Superior cytotoxicity of hydrophylic gold carboxylato complexes over hydrophylic silver carboxylates.
Langner EH; Swarts JC; Tuchscherer A; Lang H; Joone GK; VAN Rensburg CE
Anticancer Res; 2012 Jul; 32(7):2697-701. PubMed ID: 22753728
[TBL] [Abstract][Full Text] [Related]
9. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
Waern JB; Dillon CT; Harding MM
J Med Chem; 2005 Mar; 48(6):2093-9. PubMed ID: 15771451
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
[TBL] [Abstract][Full Text] [Related]
11. Ruthenium (II) nitrofurylsemicarbazone complexes: new DNA binding agents.
Cabrera E; Cerecetto H; González M; Gambino D; Noblia P; Otero L; Parajón-Costa B; Anzellotti A; Sánchez-Delgado R; Azqueta A; López de Ceráin A; Monge A
Eur J Med Chem; 2004 Apr; 39(4):377-82. PubMed ID: 15072846
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds.
Guichard SM; Else R; Reid E; Zeitlin B; Aird R; Muir M; Dodds M; Fiebig H; Sadler PJ; Jodrell DI
Biochem Pharmacol; 2006 Feb; 71(4):408-15. PubMed ID: 16360645
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antitumor activity and structure-activity relationships of a series of Ru(II) complexes.
Liu J; Zheng W; Shi S; Tan C; Chen J; Zheng K; Ji L
J Inorg Biochem; 2008 Feb; 102(2):193-202. PubMed ID: 17825915
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
Vock CA; Scolaro C; Phillips AD; Scopelliti R; Sava G; Dyson PJ
J Med Chem; 2006 Sep; 49(18):5552-61. PubMed ID: 16942028
[TBL] [Abstract][Full Text] [Related]
15. [In vitro biological activity of new platinum(II) and palladium(II) complex compounds].
Malinowska K; Modranka R; Kubiak K; Mrowicka M; Kedziora J; Klimczak A; Rutkowski M
Pol Merkur Lekarski; 2009 Jan; 26(151):52-6. PubMed ID: 19391508
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of hydrophylic silver carboxylato complexes.
Fourie E; Erasmus E; Swarts JC; Tuchscherer A; Jakob A; Lang H; Joone GK; Van Rensburg CE
Anticancer Res; 2012 Feb; 32(2):519-22. PubMed ID: 22287740
[TBL] [Abstract][Full Text] [Related]
17. 9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2006 Dec; 49(26):7816-25. PubMed ID: 17181164
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
[TBL] [Abstract][Full Text] [Related]
19. Water-soluble organometallic analogues of oxaliplatin with cytotoxic and anticlonogenic activity.
Benedetti M; Antonucci D; Migoni D; Vecchio VM; Ducani C; Fanizzi FP
ChemMedChem; 2010 Jan; 5(1):46-51. PubMed ID: 19950163
[No Abstract] [Full Text] [Related]
20. Development of ruthenium antitumor drugs that overcome multidrug resistance mechanisms.
Vock CA; Ang WH; Scolaro C; Phillips AD; Lagopoulos L; Juillerat-Jeanneret L; Sava G; Scopelliti R; Dyson PJ
J Med Chem; 2007 May; 50(9):2166-75. PubMed ID: 17419606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
